Radium-223 therapy in metastatic castration-resistant prostate cancer: baseline predictors of treatment completion and survival in a reimbursement-regulated Taiwanese cohort
Hsi-Chen Tsai, Jing‐Ren Tseng, Feng‐Yuan Liu, Chun-Te Wu et autres
tw (code pays fourni par la source)